Organoclick AB (ST:ORGC) — Stock Price

Skr0.42 SEK
▼ -1.65% today

Organoclick AB (ST:ORGC) is currently trading at Skr0.42 SEK, down 1.65% today. Over the past 52 weeks, shares have ranged between Skr0.36 and Skr1.91. This page tracks Organoclick AB's live share price on the ST exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see ORGC stock market capitalisation.

Organoclick AB (ORGC) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Organoclick AB's daily closing share price and trading volume on the ST exchange over the past year, giving a clear view of recent price momentum and liquidity.

Organoclick AB Income Statement — Revenue, Profit & Earnings by Year

Organoclick AB's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue Skr106.19 Million Skr127.23 Million Skr145.87 Million Skr115.05 Million Skr110.06 Million
Cost of Revenue Skr91.33 Million Skr95.39 Million Skr110.48 Million Skr102.11 Million Skr91.55 Million
Gross Profit Skr14.86 Million Skr31.84 Million Skr35.39 Million Skr12.94 Million Skr18.51 Million
Research & Development Skr1.52 Million Skr5.93 Million Skr6.65 Million Skr12.20 Million Skr7.50 Million
SG&A Skr15.00 Million Skr14.83 Million Skr13.80 Million Skr14.02 Million Skr11.57 Million
Total Operating Expenses Skr46.37 Million Skr41.70 Million Skr44.62 Million Skr53.89 Million Skr46.41 Million
Operating Income Skr-31.51 Million Skr-9.86 Million Skr-9.23 Million Skr-40.95 Million Skr-27.90 Million
EBITDA Skr-12.80 Million Skr5.71 Million Skr5.95 Million Skr-21.19 Million Skr-12.92 Million
EBIT Skr-31.51 Million Skr-9.82 Million Skr-9.13 Million Skr-47.82 Million Skr-28.52 Million
Interest Expense Skr6.76 Million Skr6.17 Million Skr4.96 Million Skr3.23 Million Skr2.65 Million
Income Before Tax Skr-38.29 Million Skr-16.00 Million Skr-14.09 Million Skr-41.72 Million Skr-31.17 Million
Income Tax Expense Skr-293.00K Skr181.00K Skr70.00K Skr-99.00K Skr-135.00K
Net Income Skr-36.37 Million Skr-17.97 Million Skr-15.77 Million Skr-41.62 Million Skr-31.03 Million

Organoclick AB Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Organoclick AB's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets Skr135.22 Million Skr126.98 Million Skr150.75 Million Skr162.86 Million Skr188.39 Million
Total Current Assets Skr41.20 Million Skr49.90 Million Skr68.89 Million Skr75.94 Million Skr82.48 Million
Cash & Equivalents Skr2.68 Million Skr538.00K Skr10.74 Million Skr15.20 Million Skr34.25 Million
Short-term Investments — — — — —
Net Receivables Skr11.05 Million Skr16.71 Million Skr18.02 Million Skr17.50 Million Skr14.16 Million
Inventory Skr23.59 Million Skr32.04 Million Skr36.69 Million Skr41.52 Million Skr32.39 Million
Property, Plant & Equipment Skr41.72 Million Skr28.43 Million Skr36.16 Million Skr43.63 Million Skr58.56 Million
Goodwill Skr16.79 Million Skr16.79 Million Skr16.79 Million Skr16.79 Million Skr16.79 Million
Total Liabilities Skr114.81 Million Skr89.15 Million Skr97.34 Million Skr95.30 Million Skr80.66 Million
Total Current Liabilities Skr90.91 Million Skr85.29 Million Skr84.68 Million Skr75.42 Million Skr54.38 Million
Long-term Debt Skr3.43 Million Skr1.94 Million Skr3.02 Million Skr3.72 Million Skr3.25 Million
Net Debt Skr75.11 Million Skr51.13 Million Skr51.65 Million Skr46.47 Million Skr19.29 Million
Total Stockholder Equity Skr15.18 Million Skr28.98 Million Skr44.58 Million Skr58.78 Million Skr100.33 Million
Retained Earnings Skr-313.57 Million Skr-279.70 Million Skr-263.50 Million Skr-249.29 Million Skr-207.75 Million

Organoclick AB Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Organoclick AB generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow Skr-8.29 Million Skr3.60 Million Skr533.00K Skr-21.22 Million Skr-37.69 Million
Capital Expenditures Skr2.22 Million Skr9.11 Million Skr8.61 Million Skr14.13 Million Skr14.65 Million
Free Cash Flow Skr-10.51 Million Skr-5.51 Million Skr-8.08 Million Skr-35.35 Million Skr-52.34 Million
Investing Cash Flow Skr-10.99 Million Skr-9.11 Million Skr-8.61 Million Skr-7.45 Million Skr-14.65 Million
Financing Cash Flow Skr21.42 Million Skr-4.69 Million Skr3.60 Million Skr9.62 Million Skr54.56 Million
Dividends Paid — — — — —
Stock-Based Compensation — — — — —
Depreciation Skr18.70 Million Skr15.53 Million Skr15.08 Million Skr17.30 Million Skr15.60 Million
Change in Cash Skr2.14 Million Skr-10.20 Million Skr-4.47 Million Skr-19.04 Million Skr2.22 Million

Organoclick AB Earnings History — EPS Actual vs. Analyst Estimates

Track Organoclick AB's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
May 06, 2026 -0.02 -0.02 +0.00%
Feb 12, 2026 -0.17 -0.07 -142.86%
Nov 05, 2025 -0.08 -0.07 -14.29%
Jul 18, 2025 -0.06 -0.02 -200.00%
May 06, 2025 -0.04 -0.01 -300.00%
Feb 13, 2025 -0.09 -0.08 -12.50%
Nov 06, 2024 -0.05 -0.02 -150.00%
Jul 19, 2024 -0.03 0.01 -400.00%